|
U2AF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.938010E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.727200E-01 |
| Normal-vs-Stage2 |
9.344800E-01 |
| Normal-vs-Stage3 |
3.463800E-02 |
| Normal-vs-Stage4 |
1.356240E-01 |
| Stage1-vs-Stage2 |
6.883000E-01 |
| Stage1-vs-Stage3 |
7.251700E-02 |
| Stage1-vs-Stage4 |
3.480800E-01 |
| Stage2-vs-Stage3 |
1.373970E-01 |
| Stage2-vs-Stage4 |
3.026600E-01 |
| Stage3-vs-Stage4 |
6.703200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.970950E-01 |
| Normal-vs-AfricanAmerican |
9.614400E-01 |
| Normal-vs-Asian |
7.024200E-01 |
| Caucasian-vs-AfricanAmerican |
4.714400E-01 |
| Caucasian-vs-Asian |
1.933160E-01 |
| AfricanAmerican-vs-Asian |
8.303400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.306800E-01 |
| Normal-vs-Female |
2.340400E-01 |
| Male-vs-Female |
8.142000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.997000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.586200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.119500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.174800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.065400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.463610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.656600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.125400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.580000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.267600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.82690000000352E-05 |
| Classical-VS-Follicular |
8.538400E-02 |
| Classical-VS-Other |
7.552400E-01 |
| Classical-VS-Normal |
9.396000E-01 |
| Tall-VS-Follicular |
4.734500E-02 |
| Tall-VS-Other |
2.606800E-01 |
| Tall-VS-Normal |
1.812530E-04 |
| Follicular-VS-Other |
7.595600E-01 |
| Follicular-VS-Normal |
1.236630E-01 |
| Other-VS-Normal |
7.905000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.810200E-01 |
| Normal-vs-N1 |
9.588500E-02 |
| N0-vs-N1 |
3.243600E-01 |
|
|
